For many cardiometabolic trials, time and cost factors are often a result of slow enrollment, lengthy trial duration, intensive trial-related testing and delays in signal detection.
This expert panel discussion covers how to address these challenges, while also identifying how trials will change as a result of new regulatory guidance such as the DEPICT Act.
This session will include:
- Best practices in the use of digital and home health solutions to solve key delivery pain points in cardiometabolic trials (including wearables/sensors/connected devices)
- How to leverage technology to achieve better patient representation in trials to meet the requirement of new Diversity, Equity and Inclusion regulatory guidance
- How to accelerate time to target endpoint while improving the patient experience using best-in-class digital solutions
